pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal

Antimicrob Agents Chemother. 2004 Jul;48(7):2736-8. doi: 10.1128/AAC.48.7.2736-2738.2004.

Abstract

The nucleotide sequences of the pncA genes within 55 multidrug-resistant pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates were determined. Fifty-three out of the 55 isolates were pyrazinamidase (PZase) negative. Four strains contained a wild-type pncA gene, and PZase activity was undetectable in two of these strains. Seven of the 18 identified pncA mutations found have not been described in previous studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amidohydrolases / genetics*
  • Animals
  • Antitubercular Agents / pharmacology*
  • Mutation / genetics
  • Mycobacterium tuberculosis / drug effects*
  • Portugal / epidemiology
  • Pyrazinamide / pharmacology*
  • Tuberculosis / epidemiology
  • Tuberculosis / microbiology

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Amidohydrolases
  • PncA protein, Mycobacterium tuberculosis